Background: Mutrashmari (urolithiasis) is a pathological disorder of the urinary system characterized by the formation and aggregation of urinary crystals at any site within the urinary tract, ranging from the kidneys to the urinary bladder. The condition shows a clear male predominance (male:female ratio of approximately 2:1) and has emerged as a significant medico-surgical as well as economic burden on healthcare systems worldwide.
Aims: To evaluate and compare the clinical efficacy of Mutravirechaneeya Mahakashaya and Eladi Kwath in the management of Mutrashmari (urolithiasis).
Material and Method: Forty patients with Mutrashmari were randomly allocated into two groups. In Trial Group A (n = 20), Mutravirechaneeya Mahakashaya were administered at a dose of 50 ml twice daily before meals. In Group B (n = 20), Eladi Kwath were administered at a dose of 50 ml twice daily before meals for a duration of two months.
Results: Patients treated with Mutravirechaneeya Mahakashaya showed slightly better relief in the chief complaints—namely pain, burning micturition, hematuria, and dysuria - compared to those treated with Eladi Kwath. Complete remission of symptoms of Mutrashmari was observed more frequently in patients treated with Mutravirechaneeya Mahakashaya than in those receiving Eladi Kwath.
Conclusion: Mutravirechaneeya Mahakashaya was found to be slightly more effective than Eladi Kwath in the management of Mutrashmari (urolithiasis)...
Keywords: Mutrashmari, Mutravirechaneeya Mahakashaya, Eladi Kwath, Calculas, Ashmari, Stone, Urolithiasis.
How to cite this article: Aklesh, Ojha A, Kande A, Tiwari N, Sharma M, Tiwari RK, Pandey A, "A Comparative Clinical Study To Evaluate The Efficacy Of Mutravirechaneeya Mahakashaya And Eladi Kwath In The Management Of Mutrashmari W.S.R. To Urolithiasis". Int J Drug Deliv Technol. 2026;16(2s): 330-337; DOI: 10.25258/ijddt.16.330-337